Equities

Sunrest Lifescience Ltd

SUNREST:NSI

Sunrest Lifescience Ltd

Actions
  • Price (INR)63.50
  • Today's Change1.40 / 2.25%
  • Shares traded8.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 06 2024 09:47 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the marketing of over the counter (OTC) generic pharmaceutical products manufactured by third party manufacturers in the domestic market. It deals in capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders and toothpaste. The Company’s product portfolio comprises a range of drugs like Anti-Bacterial, Anti Diarrheal, Antifungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The Company operates in different States of India, such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. The products of the Company are sold to stockists and in turn it is available at chemist shops, dispensaries, and hospitals, among others.

  • Revenue in INR (TTM)--
  • Net income in INR--
  • Incorporated2017
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sunrest Lifescience Ltd-100.00bn-100.00bn285.79m----7.39----------9.01------------------------1.11--0.4732---8.35--162.91------
Suntar Eco-City Ltd408.73m7.42m294.86m528.0039.840.281925.300.72140.00190.00190.10490.26960.30163.3033.23--0.61390.23870.79820.31453.224.322.041.612.16--0.00--124.2931.4538.28---25.27--
Global Technologies Ltd37.90m3.03m367.41m------89.079.700.000.000.000030.000080.1066--6.90--0.8516------19.87--7.99------0.3005---86.35--19.11------
Universal Health Intl Group Holding Ltd12.59bn-947.18m391.88m1.62k--0.1055--0.0311-0.1423-0.14231.850.52111.355.738.99461,745.90-10.25-25.53-22.86-33.6816.1714.18-7.58-22.510.4672-6.310.1105--1.84--43.83------
Data as of Jun 06 2024. Currency figures normalised to Sunrest Lifescience Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.